|
|
1537 NW 65th Avenue
Plantation, FL 33313 USA
phone:(954) 321-8988
fax:(954) 321-9778
|
|
| Symbol |
NPHC |
| Exchange |
OTCBB |
| Founded |
2003 |
| Employees |
|
|
|
| www.receptopharm.com
|
|
|
|
 |
| Summary Description |
| Developing patents based upon advanced receptor and molecular biology
|
|
| Management |
| Rik J. Deitsch, Chairman and Chief Executive Officer; Paul F. Reid, PhD., Chief Executive Officer; Laurence N. Raymond, Ph.D., Chief Scientific Officer; Harold H. Rumph, Director
|
| |
|
|
|
|
|
|
|
| Keywords |
| peptide technology, neurological disease, multiple sclerosis, adrenomyeloneuropathy, myasthenia gravis |
|
|
|
| Description |
|
ReceptoPharm was incorporated as Receptogen in the United States under the laws of the State of Nevada on June 4, 2001 for the purpose, among other things, of developing and acquiring patents based upon advanced receptor and molecular biology. The name was changed to ReceptoPharm in April of 2003 and the company was licensed to do business in the State of Florida.
ReceptoPharm is engaged in the discovery and development of novel and off-patent peptide technologies primarily for the prevention and treatment of disease in humans. The emphasis of ReceptoPharm's approach to the development of new therapeutic agents is based upon specialized receptor-binding proteins found in nature. The Company's primary focus is on the treatment of viral and neurological diseases.
With its' large volume of research and preclinical data ReceptoPharm believes it has identified a number of therapeutic products that have the capability to provide significant benefits for patients with such diseases as multiple sclerosis (MS), adrenomyeloneuropathy (AMN), human immunodeficiency virus (HIV), myasthenia gravis (MG), pain, and other disorders.
ReceptoPharm's principal executive offices, manufacturing, research and development facilities are located Plantation, Florida. |
|
| Technology / Differentiation |
| Anticholinergic peptide-specific nAchR-interacting proteins as potential therapeutics. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members